CHF Solutions, Inc., an early-stage medical device company, develops cardiac and coronary disease products primarily in the United States. The company focuses on commercializing the Aquadex FlexFlow system, which is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. It offers Aquadex FlexFlow consoles and the related disposable products in Singapore and Hong Kong. The company was formerly known as Sunshine Heart, Inc. and changed its name to CHF Solutions, Inc. in May 2017. CHF Solutions, Inc. was founded in 1999 and is based in Eden Prairie, Minnesota.
Industry, Sector and Symbol
Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Phone952-345-4200
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$3.55 million
Profitability
Miscellaneous
Employees46
OptionableNot Optionable
CHF Solutions (NASDAQ:CHFS) Frequently Asked Questions
What is CHF Solutions' stock symbol?
CHF Solutions trades on the NASDAQ under the ticker symbol "CHFS."
When did CHF Solutions' stock split? How did CHF Solutions' stock split work?
CHF Solutions's stock reverse split on Friday, October 13th 2017. The 1-20 reverse split was announced on Thursday, October 12th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, October 12th 2017. An investor that had 100 shares of CHF Solutions stock prior to the reverse split would have 5 shares after the split.
How were CHF Solutions' earnings last quarter?
CHF Solutions Inc (NASDAQ:CHFS) released its quarterly earnings results on Tuesday, August, 7th. The company reported ($0.93) earnings per share for the quarter, missing the consensus estimate of ($0.92) by $0.01. The firm earned $1.10 million during the quarter. CHF Solutions had a negative return on equity of 169.26% and a negative net margin of 459.89%. View CHF Solutions' Earnings History.
When is CHF Solutions' next earnings date?
What price target have analysts set for CHFS?
1 brokerages have issued twelve-month target prices for CHF Solutions' stock. Their predictions range from $3.30 to $3.30. On average, they anticipate CHF Solutions' stock price to reach $3.30 in the next year. This suggests that the stock has a possible downside of 67.2%. View Analyst Price Targets for CHF Solutions.
What is the consensus analysts' recommendation for CHF Solutions?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CHF Solutions in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CHF Solutions.
Has CHF Solutions been receiving favorable news coverage?
Press coverage about CHFS stock has trended positive on Monday, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. CHF Solutions earned a news impact score of 2.3 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 6.0 out of 10, indicating that recent media coverage is somewhat likely to have an effect on the company's share price in the immediate future.
Who are some of CHF Solutions' key competitors?
Some companies that are related to CHF Solutions include Precision Optics (PEYE), Digirad (DRAD), ENDRA Life Sciences (NDRA), Non-Invasive Monitoring Systems (NIMU), Aradigm (ARDM), Vaso (VASO), Nexeon Medsystems (NXNN), Reshape Lifesciences (RSLS), Escalon Medical (ESMC), Fc Global Realty (FCRE), Trimedyne (TMED), Magna-Lab (MAGAA), Guided Therapeutics (GTHP), SpectraScience (SCIE) and Newcardio (NWCI).
Who are CHF Solutions' key executives?
CHF Solutions' management team includes the folowing people:
- Mr. John L. Erb, Chairman, CEO & Pres (Age 70)
- Ms. Claudia Napal Drayton, Chief Financial Officer (Age 51)
- Mr. Vitaliy Epshteyn, VP of Operations & Engineering (Age 41)
- Mr. Thomas P. Lynch, VP, Gen. Counsel, Chief Compliance Officer & Sec. (Age 52)
- Ms. Sandra Eayrs, VP of HR
Who are CHF Solutions' major shareholders?
CHF Solutions' stock is owned by many different of institutional and retail investors. Top institutional shareholders include Wexford Capital LP (27.75%). Company insiders that own CHF Solutions stock include Gregory D Waller, John L Erb and Ki Yong Choi. View Institutional Ownership Trends for CHF Solutions.
Which major investors are selling CHF Solutions stock?
How do I buy shares of CHF Solutions?
Shares of CHFS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is CHF Solutions' stock price today?
One share of CHFS stock can currently be purchased for approximately $10.05.
How big of a company is CHF Solutions?
CHF Solutions has a market capitalization of $5.16 million and generates $3.55 million in revenue each year. The company earns $-13,380,000.00 in net income (profit) each year or ($520.31) on an earnings per share basis. CHF Solutions employs 46 workers across the globe.
What is CHF Solutions' official website?
How can I contact CHF Solutions?
CHF Solutions' mailing address is 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN, 55344. The company can be reached via phone at 952-345-4200 or via email at [email protected]
MarketBeat Community Rating for CHF Solutions (NASDAQ CHFS)
MarketBeat's community ratings are surveys of what our community members think about CHF Solutions and other stocks. Vote "Outperform" if you believe CHFS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CHFS will underperform the S&P 500 over the long term. You may vote once every thirty days.
